Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Ca<sub>v</sub>2.2 Blocker Multitarget Ligands
Adriano Mollica(University of Chieti-Pescara), Richard J. Lewis(AstraZeneca (Netherlands)), Reza Samavati(HUN-REN Szegedi Biológiai Kutatóközpont), Sándor Benyhe(HUN-REN Szegedi Biológiai Kutatóközpont), Ettore Novellino(Università Cattolica del Sacro Cuore), Azzurra Stefanucci(University of Chieti-Pescara), Stefano Pieretti(Istituto Superiore di Sanità), Anna Borsodi(Hungarian Academy of Sciences), Irina Vetter(Centre National de la Recherche Scientifique), Roberto Costante(University of Chieti-Pescara), Ferenc Zádor(HUN-REN Szegedi Biológiai Kutatóközpont)
Cited by 38
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422